Action and Disposition of the β3-Agonist Nebivolol in the Presence of Inflammation; An Alternative to Conventional β1-Blockers
Journal:
Current Pharmaceutical Design
Volume:
20
Page:
1311-1317
Author(s):
Forough Sanaee and Fakhreddin Jamali
Systemic Lupus Erythematosus: Old and New Susceptibility Genes versus Clinical Manifestations
Journal:
Current Genomics
Volume:
15
Page:
52-65
Author(s):
J. De Azevedo Silva, C. Addobbati, P. Sandrin-Garcia and S. Crovella
Angiogenesis in Chronic Lymphocytic Leukemia
Journal:
Current Angiogenesis (Discontinued)
Volume:
2
Page:
96-103
Author(s):
Sotirios Sachanas, Maria K. Angelopoulou, Pinelopi Korkolopoulou, Christina Kalpadakis, Pantelis Tsirkinidis, Maria Moschogiannis, Xanthi Yiakoumis, Aglaia Dimitrakopoulou, Theodoros P. Vassilakopoulos and Gerassimos A. Pangalis
Human Papilloma Virus Vaccine Associated Uveitis
Journal:
Current Drug Safety
Volume:
9
Page:
65-68
Author(s):
Henry D. Holt, David M. Hinkle, Naomi S. Falk, Frederick T. Fraunfelder and Frederick W. Fraunfelder
Hepatic Manifestations in Juvenile Systemic Lupus Erythematosus
Journal:
Recent Patents on Inflammation & Allergy Drug Discovery
Volume:
8
Page:
36-40
Author(s):
Mortada H. El-Shabrawi and Mona I. Farrag
The Relationship between Inflammatory and Oxidative Stress Biomarkers, Atherosclerosis and Rheumatic Diseases
Journal:
Current Pharmaceutical Design
Volume:
20
Page:
585-600
Author(s):
Corina Serban and Simona Dragan
Primary Antiphospholipid Syndrome and Pulmonary Hypertension
Journal:
Current Pharmaceutical Design
Volume:
20
Page:
545-551
Author(s):
Aibek E. Mirrakhimov and Nicholas S. Hill
Platelets in Rheumatic Diseases: Friend or Foe?
Journal:
Current Pharmaceutical Design
Volume:
20
Page:
552-566
Author(s):
Armen Yuri Gasparyan, Lilit Ayvazyan, Etheresia Pretorius and George D. Kitas
Transactivation of ErbB Receptors by Leptin in the Cardiovascular System: Mechanisms, Consequences and Target for Therapy
Journal:
Current Pharmaceutical Design
Volume:
20
Page:
616-624
Author(s):
Jerzy Beltowski and Anna Jazmroz-Wisniewska
Will Antirheumatic Treatment Improve Cardiovascular Outcomes in Patients with Rheumatoid Arthritis?
Journal:
Current Pharmaceutical Design
Volume:
20
Page:
486-495
Author(s):
Herwig Pieringer, Max Pichler, Erich Pohanka and Uta C. Hoppe